Gallois A - Search Results

1

Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses.

Godefroy E, Gallois A, Idoyaga J, Merad M, Tung N, Monu N, Saenger Y, Fu Y, Ravindran R, Pulendran B, Jotereau F, Trombetta S, Bhardwaj N. Godefroy E, et al. Among authors: gallois a. Cell Rep. 2014 Dec 11;9(5):1856-1870. doi: 10.1016/j.celrep.2014.10.067. Epub 2014 Nov 26. Cell Rep. 2014. PMID: 25466255 Free PMC article.

2

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity.

Bogunovic D, Manches O, Godefroy E, Yewdall A, Gallois A, Salazar AM, Marie I, Levy DE, Bhardwaj N. Bogunovic D, et al. Among authors: gallois a. Cancer Res. 2011 Aug 15;71(16):5467-76. doi: 10.1158/0008-5472.CAN-10-3988. Epub 2011 Jul 5. Cancer Res. 2011. PMID: 21730023 Free PMC article.

3

Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment.

Gallois A, Bhardwaj N. Gallois A, et al. Front Immunol. 2013 Dec 10;4:436. doi: 10.3389/fimmu.2013.00436. Front Immunol. 2013. PMID: 24339825 Free PMC article. Review.

4

Reversal of natural killer cell exhaustion by TIM-3 blockade.

Gallois A, Silva I, Osman I, Bhardwaj N. Gallois A, et al. Oncoimmunology. 2015 Jan 7;3(12):e946365. doi: 10.4161/21624011.2014.946365. eCollection 2014 Dec. Oncoimmunology. 2015. PMID: 25964857 Free PMC article.

5

A needle in the 'cancer vaccine' haystack.

Gallois A, Bhardwaj N. Gallois A, et al. Nat Med. 2010 Aug;16(8):854-6. doi: 10.1038/nm0810-854. Nat Med. 2010. PMID: 20689546 No abstract available.

6

Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.

da Silva IP, Gallois A, Jimenez-Baranda S, Khan S, Anderson AC, Kuchroo VK, Osman I, Bhardwaj N. da Silva IP, et al. Among authors: gallois a. Cancer Immunol Res. 2014 May;2(5):410-22. doi: 10.1158/2326-6066.CIR-13-0171. Epub 2014 Feb 11. Cancer Immunol Res. 2014. PMID: 24795354 Free PMC article.

7

Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines.

Speziani C, Rivollier A, Gallois A, Coury F, Mazzorana M, Azocar O, Flacher M, Bella C, Tebib J, Jurdic P, Rabourdin-Combe C, Delprat C. Speziani C, et al. Among authors: gallois a. Eur J Immunol. 2007 Mar;37(3):747-57. doi: 10.1002/eji.200636534. Eur J Immunol. 2007. PMID: 17304626 Free article.

8

Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes.

Gallois A, Lachuer J, Yvert G, Wierinckx A, Brunet F, Rabourdin-Combe C, Delprat C, Jurdic P, Mazzorana M. Gallois A, et al. J Bone Miner Res. 2010 Mar;25(3):661-72. doi: 10.1359/jbmr.090829. J Bone Miner Res. 2010. PMID: 19775202 Free article.

9

[Osteoimmunology: an integrated vision of immune and bone systems].

Gallois A, Mazzorana M, Vacher J, Jurdic P. Gallois A, et al. Med Sci (Paris). 2009 Mar;25(3):259-65. doi: 10.1051/medsci/2009253259. Med Sci (Paris). 2009. PMID: 19361389 Free article. Review. French.

10

Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling.

Sanchez-Fernandez MA, Gallois A, Riedl T, Jurdic P, Hoflack B. Sanchez-Fernandez MA, et al. Among authors: gallois a. PLoS One. 2008;3(10):e3537. doi: 10.1371/journal.pone.0003537. Epub 2008 Oct 27. PLoS One. 2008. PMID: 18953417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page